Effect of organism aging on the development of anti-PD-(L)1 therapy-associated adverse events
Immune checkpoint inhibitor (ICI)-mediated release of immune suppression involves the risk of (re)activating the immune responses to self-tissues, which are considered ‘side effects’ of this therapy, immune-related adverse events (irAEs). Although the incidence of certain types of irAEs appears to b...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Taylor & Francis Group
2025-09-01
|
| Seri Bilgileri: | Immunological Medicine |
| Konular: | |
| Online Erişim: | https://www.tandfonline.com/doi/10.1080/25785826.2025.2564474 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|